AndroGel 30 paketti (testogel)

Testogel (also known as AndroGel) is a transdermal testosterone gel prescribed for male hypogonadism when testosterone deficiency has been confirmed by clinical features and laboratory tests. The gel is applied to the skin daily, allowing testosterone to be absorbed steadily into the bloodstream, restoring levels to the normal physiological range. This helps to improve energy, mood, libido, muscle mass, bone density, and overall well-being in men with confirmed deficiency.

How to Apply Testogel

Apply Testogel once daily in the morning to clean, dry, intact skin on the shoulders, upper arms, or abdomen. Allow the gel to dry for three to five minutes before getting dressed. Wash your hands thoroughly after application.

Avoid skin-to-skin contact between the application area and other people (particularly women and children) until the gel has fully dried or you have washed the area. Testosterone can transfer to others through direct skin contact and cause unwanted hormonal effects. Ideally, shower before skin contact with a partner to minimise any risk of transfer.

The usual starting dose is 50 mg (5 g of 1% gel or one sachet of Testogel 50 mg) applied once daily. Dose is adjusted based on serum testosterone levels, typically measured two to four weeks after starting, with the aim of achieving mid-normal range levels.

Common Side Effects

Common side effects include:

• Skin reactions at the application site (redness or itching)
• Acne
• Headache
• Raised PSA (prostate-specific antigen) levels
• Polycythaemia (raised red blood cell count, which thickens the blood)

Polycythaemia requires monitoring with regular blood tests during treatment. Your doctor will check your haematocrit and PSA at regular intervals. Tell your doctor if you notice unexpected mood changes, increased aggression, or acne, as these may indicate the dose needs adjusting.

Risk of transference: testosterone can transfer to others through skin contact. Cover the application site with clothing after the gel has dried and wash the area before anticipated skin contact. Monitor haematocrit, PSA, and liver function regularly during treatment.

Contraindicated in known or suspected prostate or breast cancer, severe cardiac, hepatic, or renal insufficiency, and in women (particularly pregnant or breastfeeding women).